Medicover operates in the healthcare industry. The company is an international healthcare and diagnostics company and focuses on providing medical services and laboratory analyses. The company's services are aimed at individuals and companies that need fast and accessible care. Medicover was founded in 1994 and is headquartered in Stockholm, Sweden.
* Strong Q1 beat with 110bps margin expansion on adj. EBITDA * Adj. EBITDA up 1% for '26e-'28e on Q1 beat * FVR unchanged at SEK 190-270 on minor estimate revisions A solid start to '26 despite weather drag Q1 was 8%/6% above ABGSCe/Infront consensus...
* 8%/6% adj. EBITDA vs ABGSCe/Infront cons in Q1 * Cons estimates likely up 1-3% on adj. EBITDA '26e * Model proved itself despite the weather headwind we flagged Q1 results Medicover reported a strong start to '26 with sales in-line vs cons and a clear...
* Q1'26 numbers due on 29 April at 07:45 CET * Near-term caution, but the model should continue to prove itself * Fair value range down to SEK 190-270 (200-280) Q1'26 should be marked by cold weather We expect colder-than-usual temperatures and severe...
* Focus on sport/wellness, dental and smaller centres * Adj. EBITDAaL margin expansion: 11.7% to 12.9% during '26e-'28e * ~25% below its historical average on NTM EV/EBITDA Polish capex skewing to margin-accretive growth levers Last Wednesday we visited...
* Expanding margins on the back of a maturing asset base * A clear and differentiated strategy for each of the four core markets * Join us for our 4 March site visit in Warsaw (RSVP link below) From expansion to utilisation and margin delivery The key...
* A solid report and new targets underpin long-term case * Adj. EBITDA largely unchanged for '26e-'27e, sales slightly down * We now expect a 15% adj. EBITDA CAGR '25-'28e Solid Q4 closes a strong year Q4 was in line with estimates and confirmed the ...
* 0%/-3% adj. EBITDA vs ABGSCe/Infront cons in Q4 * Cons estimates likely flat on adj. EBITDA '26e, up mid-term * New targets 9% above ABGSCe target expectation on earnings Q4 results Medicover reported a solid Q4 with sales in-line and a small miss ...
